Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO IV-ACS randomised trial

2001-06-16

The Lancet , Volume 357 - Issue 9272 p. 1915- 1924

Additional Metadata
Persistent URL	doi.org/10.1016/S0140-6736(00)05060-1, hdl.handle.net/1765/55018
Journal	The Lancet
Organisation	Department of Cardiology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Simoons, M. (2001). Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO IV-ACS randomised trial. The Lancet, 357(9272), 1915–1924. doi:10.1016/S0140-6736(00)05060-1

Publication